Table 1. The correlation of clinicopathologic variables of NSCLC with BRF2 and MVD.
BRF2 overexpression | MVD | |||||||
Variable | No. of patients | no | yes | p | Low | High | P | |
Age | ≤65 years | 43 | 21 | 22 | 0.498 | 17 | 26 | 0.453 |
>65 years | 64 | 27 | 37 | 30 | 34 | |||
Gender | Male | 51 | 20 | 31 | 0.263 | 22 | 29 | 0.875 |
Female | 56 | 28 | 28 | 25 | 31 | |||
Smoking | No | 53 | 24 | 29 | 0.931 | 27 | 26 | 0.147 |
Yes | 54 | 24 | 30 | 20 | 34 | |||
Histology | Adeno | 48 | 25 | 23 | 0.175 | 22 | 26 | 0.720 |
Squamous | 59 | 23 | 36 | 25 | 34 | |||
Differentiation | Well | 23 | 11 | 12 | 0.086 | 7 | 16 | 0.195 |
Moderate | 54 | 19 | 35 | 28 | 26 | |||
Poor | 30 | 18 | 12 | 12 | 18 | |||
Invasion depth | T1 | 47 | 23 | 24 | 0.453 | 27 | 20 | 0.013 |
T2 | 60 | 25 | 35 | 20 | 40 |